Renovaro Biosciences Inc Cash Flow Quality Index

Latest as of March 2025: 0.00x

Renovaro Biosciences Inc cash flow quality index. Renovaro Biosciences Inc (RENB) has a Cash Flow Quality Index of 0.00x as of March 2025. Operating cash flow of $-1.49 Million is below net income of $39.68 Trillion, suggesting accrual-heavy earnings not yet converted to cash. See Renovaro Biosciences Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

0.00x
Operating CF / Net Income

Operating Cash Flow

$-1.49 Million
USD

Net Income

$39.68 Trillion
USD

Data as of

Mar 2025
Most recent filing

Renovaro Biosciences Inc Cash Flow Quality Index by Year (None–None)

Renovaro Biosciences Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Renovaro Biosciences Inc. For the full cash flow conversion analysis, see cash flow conversion of Renovaro Biosciences Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.